Global Digital Health Market Expected to Garner $1,045.8 Billion in Revenue and Grow at a CAGR of 33.4% during the Estimated Timeframe 2020-2027 | Research Dive
October 10, 2022 09:02 ET
|
Research Dive
New York, USA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global digital health market is anticipated to generate a revenue of $1,045.8 billion by...
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 18, 2022 10:30 ET
|
Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
Pharmaceutical Drug Delivery Market Revenue to Cross $2296.17 Bn, Globally by 2027 at 6.6% CAGR | Exclusive Report by The Insight Partners
July 26, 2022 10:30 ET
|
The Insight Partners
New York, July 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by...
Community Org Kicks Off Conquer Diseases Movement
June 10, 2022 17:00 ET
|
Life ProLong Center
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- The Life ProLong Center, a community well-being-oriented organization, officially kicked off its "Conquer Diseases" event in June 2022. Since the World...
Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
December 02, 2021 10:00 ET
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference
November 10, 2021 16:15 ET
|
Vyant Bio, Inc.
Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
August 11, 2021 09:00 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
IMAC Holdings to Present at the LD Micro Virtual Invitational Conference on June 8, 2021
June 02, 2021 09:02 ET
|
IMAC Holdings, Inc.
Brentwood, Tenn., June 02, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation...
IMAC Regeneration Centers Annual Analysis Shows 81% of Patients Report Improvement in Functional Outcomes from Treatment of Musculoskeletal Conditions
May 27, 2021 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., May 27, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Holdings to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on Tuesday, June 1, 2021
May 26, 2021 06:01 ET
|
IMAC Holdings, Inc.
Brentwood, Tenn, May 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation...